Hematological malignancies mimicking rheumatic syndromes: case series and review of the literature

Rheumatology International
Gil BornsteinChagai Grossman

Abstract

It is well established that some rheumatic syndromes (RS) are associated with several hematological malignancies. We aimed to describe the clinical course of patients with hematological malignancies mimicking RS. We studied a series of four patients presenting with apparent RS who were eventually diagnosed with hematological malignancies, and reviewed the relevant literature. Our series consisted of 4 patients, with a mean age of 62.8 ± 20.3 years, who presented to our rheumatology unit between December 2012 and March 2018. Two patients were initially diagnosed with polyarthritis. One of these patients was eventually diagnosed with multiple myeloma and amyloidosis and the other was diagnosed with angioimmunoblastic T-cell lymphoma. The third patient was initially diagnosed with migratory arthritis and was eventually diagnosed with acute myeloid leukemia. The fourth patient was initially diagnosed with giant cell arteritis and eventually diagnosed with anaplastic large T-cell lymphoma. All the patients displayed a very good response to corticosteroid treatment. Vigilance for occult malignancy is essential in the diagnostic workup of RS. A good response to corticosteroids may constitute a major diagnostic pitfall in patients with...Continue Reading

References

Aug 1, 1991·Baillière's Clinical Rheumatology·J A Rennie, I A Auchterlonie
Apr 1, 1988·Arthritis and Rheumatism·X MarietteE Oksenhendler
Jan 1, 1994·Rheumatology International·U A WalkerH H Peter
Aug 1, 1994·Seminars in Arthritis and Rheumatism·T I EvansK M Sanders
Sep 1, 1994·British Journal of Rheumatology·G T Thomson
Feb 17, 1993·Journal of the National Cancer Institute·G GridleyJ F Fraumeni
Apr 1, 1993·Arthritis and Rheumatism·M Abu-ShakraP Lee
Feb 4, 1998·Current Opinion in Rheumatology·J A Aviña-ZubietaC Lavalle
Jan 1, 1999·Chest·K S SridharR D Altman
Jan 23, 1999·Current Opinion in Rheumatology·M EhrenfeldY Shoenfeld
Sep 1, 1999·Seminars in Arthritis and Rheumatism·J E NaschitzD Yeshurun
Apr 17, 2001·Annals of the Rheumatic Diseases·M Abu-ShakraY Shoenfeld
Apr 25, 2003·Lancet·A B AlexandroffN P Burrows
Aug 11, 2005·Rheumatology International·Csilla AndrásKatalin Dankó
Nov 18, 2006·Autoimmunity Reviews·Eva SzekaneczZoltán Szekanecz
Feb 10, 2007·Autoimmunity Reviews·Lorenzo LorussoGiovanni Ricevuti
Feb 19, 2008·Current Opinion in Rheumatology·Jochanan E Naschitz, Itzhak Rosner
May 20, 2008·Autoimmunity Reviews·Vito RacanelliFederico Perosa
Jun 17, 2008·Internal Medicine·Nagaaki KatohShu-ichi Ikeda
Nov 20, 2009·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Nilüfer AlpaySevgi Kalayoğlu-Beşişik
Apr 8, 2010·Rheumatology·Bhaskar DasguptaUNKNOWN BSR and BHPR Standards, Guidelines and Audit Working Group
Apr 20, 2010·Arthritis Research & Therapy·Yi-Ju ChenYun-Ting Chang
Jan 11, 2012·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Thomas V Colby
Nov 21, 2013·Modern Rheumatology·Hiroyuki YamashitaAkio Mimori
Jan 18, 2014·International Journal of Rheumatic Diseases·Bunyamin KisacikMehmet Sayarlioglu
Nov 6, 2014·Arthritis & Rheumatology·Ami A ShahAntony Rosen
Jun 27, 2015·Current Rheumatology Reports·Hongbin LiQingping Yao

❮ Previous
Next ❯

Citations

May 2, 2019·Rheumatology International·Hava Üsküdar TekeCengiz Korkmaz
Nov 9, 2018·Case Reports in Rheumatology·Scott SchoningerNatasa Milojkvovic

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Related Papers

Anales de medicina interna : organo oficial de la Sociedad Española de Medicina Interna
P Khosravi ShahiS Encinas García
Journal of Oral and Maxillofacial Surgery : Official Journal of the American Association of Oral and Maxillofacial Surgeons
Olawunmi FatusiKayode Adelusola
© 2022 Meta ULC. All rights reserved